Relationship between serum uric acid levels and urinary albumin excretion in patients with heart failure

Acta Cardiologica

Volumn 63, Issue 2, 2008, Pages 191-195

  Pinelli, Massimiliano ^a   Bindi, Massimo ^a,b   Moroni, Federica ^a   Castiglioni, Maido ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b NONE   (Italy)

Author keywords

Heart failure; Serum uric acid; Urinary albumin excretion

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; URIC ACID; XANTHINE; XANTHINE OXIDASE;

AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTION; REGRESSION ANALYSIS; RELIABILITY; UNIVARIATE ANALYSIS; URIC ACID BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; VASCULAR DISEASE;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; HYPERURICEMIA; MALE; NATRIURETIC PEPTIDE, BRAIN; NEPHELOMETRY AND TURBIDIMETRY; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 42249098721     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.63.2.2029527     Document Type: Article

References (28)

1. Bakhtiiarov ZA. Changes in xanthine oxidase activity in patients with circulatory failure [in Russian]. Ter Arkh 1989; 61: 68-9.
2. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, Stevenson JC, Coats AJS. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997; 18: 858-65.
3. Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJS. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart 1997; 78: 39-43.
4. Doehner W, Rauchhaus M, Florea VG, Sharma R, Bolger AP, Davos CH, Coats AJS, Anker SD. Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance. Am Heart J 2001; 141: 792-9.
5. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869-74.
6. de Zeeuw D. Albuminuria, not only a cardiovascular/renal risk marker but also a target for treatment? Kidney Int 2004; 66 (suppl 92): S2-S6.
7. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, Tavazzi L, Smiseth OA, Gavazzi A, Haverich A, Hoes A, Jaarsma T, Korewicki J, Levy S, Linde C, Lopez-Sendon JL, Nieminen MS, Piérard L, Remme WJ. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-40.
8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
9. Torre-Amione G. immune activation in chronic heart failure. Am J Cardiol 2005; 95 (11A): 3C-7C.
10. Pasotti M, Repetto A, Tavazzi L, Arbustivi E. Genetic predisposition to heart failure. Med Clin N Am 2004; 88: 1173-92.
11. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistence in heart failure. Eur Heart J 1994; 15: 1528-32.
12. Hassoun PM, Shedd A, Lanzillo J, Thappa V, Landman M, Fanburg B. Inhibition of pulmonary artery smooth muscle cell growth by hypoxanthine, xanthine and uric acid. Am J Respir Cell Mol Biol 1992; 6: 617-24.
13. Terada LS, Guidot DM, Leff JA, Willingham IR, Hanley ME, Piermattei D, Repine JE. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 1992; 89: 3362-6.
14. Mattei P, Arzilli F, Giovannetti R, Penno G, Arrighi P, Taddei S, Salvetti A. Microalbuminuria and renal haemodynamics in essential hypertension. Eur J Clin Invest 1997; 27: 755-60.
15. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962-7.
16. Liu JE, Robbins DC, Palmieri V, Bella JN, Roman MJ, Fabsitz R, Howard BV, Welty TK, Lee ET, Devereux RB. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the strong heart study. J Am Coll Cardiol 2003; 41: 2022-8.
17. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcome Prevention Evaluation study Investigators. Lancet 2000; 355: 253-9.
18. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure. Circulation 2002; 106: 3073-8.
19. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997; 100: 2153-7.
20. Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002; 283: F1105-F1110.
21. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-42.
22. Waring WS, Webb DJ, Maxwell SRJ. Effect of local hyperuricemia on endothelial function in the human forearm vascular bed. Br J Clin Pharmacol 2000; 49: 511.
23. Kanabrocki EL, Third JL, Ryan MD, Nemchausky BA, Shirazi P, Schewing LE, McCormick JB, Hermida RC, Bremner WF, Hoppensteadt DA, Fareed J, Olwin JH. Circadian relationship of serum uric acid and nitric oxide. JAMA 2000; 283: 2240-1.
24. Santos CXC, Anjos EI, Augusto O. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 1999; 372: 282-94.
25. Yamaguchi H, Yoshida J, Yamamoto K, Sakata Y, Mano T, Akehi N, Hori M, Lim YJ, Mishima M, Masuyama T. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43: 55-60.
26. Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Zeni P, Zardini P. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J 2002; 143: 1107-11.
27. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 104: 2407-11.
28. Kittleson MM, Hare JM. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure. Eur Heart J 2005; 26: 1458-60.